These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23296566)

  • 21. Cyclin T1/CDK9 interacts with influenza A virus polymerase and facilitates its association with cellular RNA polymerase II.
    Zhang J; Li G; Ye X
    J Virol; 2010 Dec; 84(24):12619-27. PubMed ID: 20943989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity.
    Hole AJ; Baumli S; Shao H; Shi S; Huang S; Pepper C; Fischer PM; Wang S; Endicott JA; Noble ME
    J Med Chem; 2013 Feb; 56(3):660-70. PubMed ID: 23252711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of novel 4,4'-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer.
    Gao G; Li J; Cao Y; Li X; Qian Y; Wang X; Li M; Qiu Y; Wu T; Wang L; Fang M
    Eur J Med Chem; 2023 Dec; 261():115858. PubMed ID: 37837671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the Cdk9/Cyclin T1 complex in T cell differentiation.
    Leucci E; De Falco G; Onnis A; Cerino G; Cocco M; Luzzi A; Crupi D; Tigli C; Bellan C; Tosi P; Leoncini L; Giordano A
    J Cell Physiol; 2007 Aug; 212(2):411-5. PubMed ID: 17352406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of selected 7H-pyrrolo[2,3-d]pyrimidine derivatives as novel CDK9/CyclinT and Haspin inhibitors.
    Pieterse L; Beteck RM; Baratte B; Jesumoroti OJ; Robert T; Ruchaud S; Bach S; Legoabe LJ
    Chem Biol Interact; 2021 Nov; 349():109643. PubMed ID: 34508710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.
    Németh G; Greff Z; Sipos A; Varga Z; Székely R; Sebestyén M; Jászay Z; Béni S; Nemes Z; Pirat JL; Volle JN; Virieux D; Gyuris Á; Kelemenics K; Ay E; Minarovits J; Szathmary S; Kéri G; Orfi L
    J Med Chem; 2014 May; 57(10):3939-65. PubMed ID: 24742150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells.
    De Falco G; Leucci E; Onnis A; Bellan C; Tigli C; Wirths S; Cerino G; Cocco M; Crupi D; De Luca A; Lanzavecchia A; Tosi P; Leoncini L; Giordano A
    J Cell Physiol; 2008 Apr; 215(1):276-82. PubMed ID: 18205180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
    Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
    Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
    Sonawane YA; Taylor MA; Napoleon JV; Rana S; Contreras JI; Natarajan A
    J Med Chem; 2016 Oct; 59(19):8667-8684. PubMed ID: 27171036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1.
    Feichtinger S; Stamminger T; Müller R; Graf L; Klebl B; Eickhoff J; Marschall M
    J Gen Virol; 2011 Jul; 92(Pt 7):1519-1531. PubMed ID: 21450947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update.
    Wu T; Qin Z; Tian Y; Wang J; Xu C; Li Z; Bian J
    J Med Chem; 2020 Nov; 63(22):13228-13257. PubMed ID: 32866383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional inactivation of Cdk9 through oligomerization chain reaction.
    Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
    Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
    Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
    Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
    Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
    Rice AP
    Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90.
    Breuer D; Kotelkin A; Ammosova T; Kumari N; Ivanov A; Ilatovskiy AV; Beullens M; Roane PR; Bollen M; Petukhov MG; Kashanchi F; Nekhai S
    Retrovirology; 2012 Nov; 9():94. PubMed ID: 23140174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.
    Kapasi AJ; Clark CL; Tran K; Spector DH
    J Virol; 2009 Jun; 83(11):5904-17. PubMed ID: 19297489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.